Several long time posters have suggested tomorrow will not bring anything new or meaningful to light as it doesn’t fit the companies pattern of releasing news.
If tomorrow is another nothing-burger, I think it will be time to consider the difficult prospect that something is seriously amiss with the Lm platform. Yes, there haven’t been any major trial misses or outright failures but after a number of BP’s have kicked the tires, none have made a serious commitment and some have simply walked away and moved on.
Lm may yet find a medical niche to fill but dreams of it being a big impact medical game changer are quickly becoming harder to defend based on all the cumulative evidence at hand. A tough reality to accept if thats what’s unfolding.
G.B.
News 
Market Data 
Discover 
